Table 2.
Influence of immobilization-radiation factors on AOS enzyme activities (M±m).
| Object of the study | Group I | Group II | Group III | Group IV | |
|---|---|---|---|---|---|
| CT r.u. | Liver | 75.41±6.18 | 51.03±4.28 * | 57.92±4.39 * | 45.17±3.72 ** |
| Spleen | 60.28±4.82 | 26.39±2.32 *** | 48.22±3.08 * | 38.96±3.09 * | |
| Thymus | 54.47±4.11 | 26.17±2.38 *** | 37.58±3.05 * | 36.01±3.39 * | |
| Adrenal glands | 62.41±5.18 | 52.01±4.55 | 60.43±4.49 | 53.08±4.45 | |
| Lymph nodes | 51.19±4.24 | 32.49±2.34 * | 41.34±2.31 * | 37.01±3.11 * | |
| LY/blo | 90.15±8.28 | 80.21±7.11 | 73.41±5.63 | 69.87±5.26 * | |
| GPx mcM/g min | Liver | 166.09±14.51 | 145.63±12.14 | 128.11±8.38 * | 121.01±10.42 * |
| Spleen | 255.89±21.09 | 163.33±11.23 * | 183.45±12.53 * | 155.01±12.48 ** | |
| Thymus | 118.01±8.62 | 98.87±8.55 | 112.37±9.57 | 87.05±5.94 * | |
| Adrenal glands | 166.95±11.28 | 139.81±10.24 | 145.22±11.31 | 152.34±11.68 | |
| Lymph nodes | 223.28±19.13 | 191.13±16.22 | 212.81±17.43 | 188.34±13.07 | |
| LY/blo | 431.89±37.07 | 323.01±27.32 * | 301.21±22.83 * | 245.55±21.49 ** | |
| GSR mcM/g min | Liver | 24.31±2.08 | 15.01±1.11 ** | 18.41±1.17 * | 18.21±1.31 * |
| Spleen | 36.23±3.09 | 20.32±1.59 ** | 26.28±2.13 * | 21.28±1.68 ** | |
| Thymus | 30.24±2.11 | 22.28±1.59 * | 25.91±2.04 | 21.76±2.44 * | |
| Adrenal glands | 23.32±2.01 | 20.02±1.65 | 17.58±1.41 * | 22.23±1.91 | |
| Lymph nodes | 26.12±2.14 | 18.37±1.28 * | 20.19±1.59 * | 22.74±2.11 | |
| LY/nursafina blo | 9.12±0.64 | 3.13±0.24 *** | 7.21±0.55 * | 6.04±0.49 * |
differences with the control group are significant: * – p<0.05, ** – p<0.01, *** – p<0.001.